People · Operator
Named in public records as an officer, director or promoter · active 2010–2025 · Software / Tech, Other Health Care, Biotechnology, Pharmaceuticals, Agriculture, AI / ML
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Verint Systems Inc | — | Software / Tech | Series D+ | $400.0M | $5.2B | 2020 |
| RESTOR3D, Inc. | — | Other Health Care | Series C | $239.2M | $522.3M | 2017 |
| ReAlta Life Sciences, Inc. | — | Biotechnology | Series B | $108.3M | $146.1M | 2023 |
| Synedgen, Inc. | — | Pharmaceuticals | Series A | $24.3M | $8.3M | 2015 |
| Real Kansas Meats, LLC | — | Agriculture | Series A | $6.0M | $24.1M | 2024 |
| Journey.ai, Inc. | — | AI / ML | Series A | $4.2M | $91.0M | 2021 |
| My Coi, Llc | — | Other Technology | Seed | $2.5M | $73.4M | 2015 |
| CardStar | — | Other Technology | Pre-Seed | $1.7M | $11.9M | 2010 |
Andrew Miller at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Andrew Miller on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| John Morgan | 1 | 9 |
| Douglas Robinson | 1 | 7 |
| Paul Grint | 1 | 5 |
| Richard Nottenburg | 1 | 5 |
| John Egan | 1 | 5 |
| Jason Wright | 1 | 5 |
| Kenneth Gall | 1 | 5 |
| Kurt Jacobus | 1 | 5 |
| Emma Reeve | 1 | 4 |
| Ken Gall | 1 | 4 |
| Mark McDowell | 1 | 4 |
| Michael Pratt | 1 | 4 |
| Douglas Kohrs | 1 | 4 |
| Michael Porter | 1 | 3 |
| William Kurtz | 1 | 3 |
| Thomas MacIsaac | 1 | 3 |
| John Harding | 1 | 3 |
| JAMES STUBBS | 1 | 3 |
| ANDREW SUMMERS | 1 | 3 |
| Penelope Herscher | 1 | 3 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.